Expedia is identified as an undervalued cyclical stock favored by hedge funds. Following strong second-quarter 2025 results, Citi raised its price target on the company from $177 to $206. However, the firm maintained a Neutral rating on the stock, indicating a positive view on recent performance but a cautious outlook on its future potential.